ESC 365 - The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: The Liverpool AF-Falls Project. A systematic review and meta-analysis

EHRA Premium Access

The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: The Liverpool AF-Falls Project. A systematic review and meta-analysis

Session: ePosters Day 2

Topic: Oral Anticoagulation

Speaker: Doctor T. Galvain (Liverpool, GB)

Event: EHRA 2022

Congress Presentation

About the speaker

Doctor Thibaut Galvain

Liverpool John Moores University, Liverpool (United Kingdom of Great Britain & Northern Ireland)

0 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhia, UA)

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Access the full session

ePosters Day 2

Speakers: Doctor T. Galvain, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

Related content

EHRA Premium Access

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

4 April 2022

ESC Premium Access

Trajectories of high-sensitivity cardiac troponin I in the two decades before cardiovascular death in whitehall II

30 August 2021

Open Access

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

27 August 2021

ESC 365 is supported by